Nichi-Iko Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nichi-Iko Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Sawai Pharmaceutical Co., Ltd.
sales of 132.43 billion Japanese Yen [US$1.17 billion]
of which 100%
was Pharmaceutical Business),
KYORIN Holdings, Incorporation
(115.37 billion Japanese Yen [US$1.02 billion]
of which 95%
was Pharmaceutical Business), and
Santen Pharmaceutical Company Limited
(199.10 billion Japanese Yen [US$1.75 billion]
of which 98%
was Pharmaceutical Products).
Nichi-Iko Pharmaceutical Company Limited reported sales of ¥163.37 billion (US$1.44 billion)
March of 2017.
increase of 13.8%
versus 2016, when the company's sales were ¥143.51 billion.
Sales at Nichi-Iko Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 102%).